2-phenylpropionic acid derivatives and pharmaceutical...

Organic compounds -- part of the class 532-570 series – Organic compounds – Sulfonate esters

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S233000, C548S568000, C514S033000, C514S428000, C514S517000

Reexamination Certificate

active

08039656

ABSTRACT:
4-(trifluoromethanesulfonyloxyphenyl)propionic acid derivatives and pharmaceutical composition containing such compounds are useful in inhibiting the chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The compounds are used for the prevention and treatment of pathologies deriving from said activation. Notably, these metabolites are devoid of cyclo-oxygenase inhibition activity and are particularly useful in the treatment of neutrophil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigoid, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.

REFERENCES:
patent: WO 00/24710 (2000-05-01), None
patent: WO 01/58852 (2001-08-01), None
patent: WO 02/068377 (2002-09-01), None
patent: WO 03/043625 (2003-05-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-phenylpropionic acid derivatives and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-phenylpropionic acid derivatives and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-phenylpropionic acid derivatives and pharmaceutical... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4252740

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.